ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1744

Regulatory B Cells Supress the Progression of Fatal Autoimmunity in Lupus-Prone Mice

Yuriy Baglaenko1, Nan-Hua Chang2, Evelyn Pau3 and Joan E. Wither4, 1Immunology, University of Toronto, Toronto, ON, Canada, 2Genetics and Development, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 3Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 41E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: B cells, regulatory cells and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus (SLE) is a complex multisystem autoimmune disorder characterized by the production of anti-nuclear antibodies (ANA) which form immune complexes and promote end-organ damage. Studies in our lab have focused on identifying genetic defects that contribute to a loss of immune regulation in autoimmune prone New Zealand Black (NZB) mice. Previous work has shown that the introgression of a NZB chromosome 1 (c1) interval extending from 135 to179 Mb onto the non-autoimmune C57BL/6 (B6) background results in increased B and T cell activation, elevated ANA levels, and fatal kidney disease. Despite the presence of mapped susceptibility loci on NZB c4, introgression of an interval extending from 30 to 150Mb onto the B6 background resulted in the expansion of splenic NKT and CD5+ B cells in the absence of autoimmunity. To further investigate the role of NZB c4 in autoimmunity, bicongenic (c1c4) mice were produced with both NZB c4 and c1 intervals. Although bicongenic mice had c1 autoimmune augmenting genes, c1c4 mice had reduced renal disease, increased survival, and a shift towards less pathogenic IgG1 autoantibodies. Interestingly, bicongenic mice retained the expansion of splenic CD5+ B cells. Recent studies on experimental autoimmune encephalitis and arthritis models have identified a non-redundant role for a population of IL-10 producing CD5+CD1dhi regulatory B cells in preventing disease progression. Given the consistent expansion of splenic CD5+ B cells in bicongenic mice, we sought to investigate their role in the suppression of fatal autoimmunity.

Methods: Cellular phenotypes were examined by flow cytometry of de novo splenocytes. Intracellular production of IL-10 or IFNγ and IL-17 was measured following 4 to 5 hour stimulation with LPS, PMA and Ionomycin or PMA and Ionomycin, respectively. Serum levels of anti-nuclear antibodies were measured by ELISA. Adoptive transfer experiments were performed by injecting 5-10 million B cells intravenously into c1.Thy1aIgHa recipients.

Results: There was a significant increase in IL-10 producing B cells in bicongenic and c4 mice when compared to B6 and c1 controls. Interestingly, the expansion of IL-10 producing cells in c1c4 and c4 mice is distinct from previously documented B regulatory populations and localizes to the CD5+CD1dint B cell compartment. There was an inverse correlation between the levels of anti-ssDNA IgG and the frequency of IL-10 producing B cells in c1c4 but not B6 mice suggesting that they may play a role in disease suppression. There was no correlation between the proportion of conventional Treg or iNKT cells and anti-ssDNA IgG antibodies. In support of a direct suppressive capacity for the expanded CD5+ B cells, adoptive transfer of total B cells from c4, but not B6, mice into autoimmune prone c1.Thy1aIgHa recipients reduced the proportion of activated B cells, germinal centre B cells, memory/effector T cells, and IFN-g or IL-17-secreting T cells.

Conclusion: Taken together, these data indicate the presence of a phenotypically novel IL-10 producing B cell population in c4 mice which can suppress the progression of fatal autoimmunity.


Disclosure:

Y. Baglaenko,
None;

N. H. Chang,
None;

E. Pau,
None;

J. E. Wither,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulatory-b-cells-supress-the-progression-of-fatal-autoimmunity-in-lupus-prone-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology